Dori Pelled

Title: Dori Pelled: Innovator in Glycolipid-Storage Disease Research

Introduction

Dori Pelled is a notable inventor based in Rehovot, Israel. He has made significant contributions to the field of medical research, particularly in the area of glycolipid-storage diseases. His work focuses on developing methods to screen for inhibitors of phospholipid synthesis, which is crucial for treating conditions like Gaucher disease.

Latest Patents

Dori Pelled holds a patent for "Methods of screening for inhibitors of phospholipid synthesis related to glycolipid-storage diseases." This invention discloses methods for identifying compounds that inhibit novel targets in the enzymatic pathway of phospholipid synthesis. The compounds are intended to treat patients affected by glycolipid storage diseases, specifically targeting the accumulation of phosphatidylcholine (PC) that occurs due to the activation of CTP:phosphocholine cytidylyltransferase (CCT) upon glucosylceramide (GlcCer) accumulation.

Career Highlights

Throughout his career, Dori Pelled has been associated with Yeda Research and Development Co. Ltd. His innovative work has positioned him as a key figure in the research community, particularly in the study of glycolipid-storage diseases. His contributions have the potential to significantly impact the treatment options available for patients suffering from these conditions.

Collaborations

Dori Pelled has collaborated with esteemed colleagues such as Anthony Futerman and Jacques Bodennec. These partnerships have enhanced his research efforts and contributed to the advancement of knowledge in the field.

Conclusion

Dori Pelled's work in the realm of glycolipid-storage diseases exemplifies the importance of innovation in medical research. His patent and collaborations highlight his commitment to improving treatment options for patients. His contributions are invaluable to the ongoing fight against these challenging diseases.